Balyasny funds disclose 6.18% Verastem (VSTM) stake via shares and warrants
Rhea-AI Filing Summary
Balyasny Asset Management and affiliates report a 6.18% beneficial stake in Verastem Inc. common stock. The group reports beneficial ownership of 4,767,154 shares, consisting of 3,195,726 shares and 1,571,428 shares issuable upon exercise of warrants that are subject to a 9.99% beneficial ownership blocker.
The percentage is based on 77,154,709 Verastem shares outstanding as of November 17, 2025. The filing states the position is held in the ordinary course of business and not for the purpose of changing or influencing control of Verastem.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What stake in Verastem Inc. (VSTM) does Balyasny report in this Schedule 13G/A?
Balyasny and related entities report beneficial ownership of 4,767,154 Verastem shares, or about 6.18% of the common stock. This includes both currently held shares and shares issuable upon exercise of warrants, subject to ownership limits.
How is Balyasny’s 6.18% Verastem (VSTM) ownership stake calculated?
The 6.18% ownership is based on 77,154,709 Verastem shares outstanding as of November 17, 2025. Balyasny’s reported 4,767,154 shares, including warrant shares, is divided by that outstanding share count disclosed in Verastem’s November 17, 2025 prospectus.
What securities make up Balyasny’s Verastem (VSTM) position in this filing?
The reported position consists of 3,195,726 Verastem common shares and 1,571,428 additional shares issuable upon exercise of warrants. The warrants are subject to a 9.99% beneficial ownership limitation, which restricts exercises that would push ownership above that threshold.
Does Balyasny’s Verastem (VSTM) filing indicate an attempt to influence control?
No. The certification states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Verastem, nor in connection with any transaction having that control-related purpose or effect.
What is the significance of the 9.99% beneficial ownership limitation on Verastem warrants?
The warrants include a 9.99% beneficial ownership limitation, preventing exercises that would push the holder’s beneficial ownership above 9.99% of outstanding shares. This contractual blocker caps how many warrant shares can be exercised at any time, constraining the maximum reportable stake.